Insider Buying: Beamtree (ASX:BMT) Insider Buys 278,061 Shares of Stock

Beamtree Holdings Limited (ASX:BMT) insider Brad Lancken acquired 278,061 shares of the company’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were acquired at an average cost of A$0.22 per share, with a total value of A$62,285.66.

Beamtree Stock Performance

The company has a market cap of $84.04 million, a PE ratio of -16.41 and a beta of 1.86. The company has a current ratio of 1.28, a quick ratio of 1.49 and a debt-to-equity ratio of 3.52.

About Beamtree

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data.